Home > Risk assessment of new psychoactive substances (NPS).

European Monitoring Centre for Drugs and Drug Addiction. (2022) Risk assessment of new psychoactive substances (NPS).

External website: https://www.emcdda.europa.eu/publications/topic-ov...


Risk assessment is the second step in the three-step legal framework designed to allow the European Union (EU) to rapidly detect, assess, and respond to health and social threats caused by new psychoactive substances (NPS). On this page you can learn the role of the risk assessment in the EU earl warning system (EWS) and how it support decision-making on the need to control new psychoactive substances at EU level.

On the EMCDDA webpage:

  • About EU risk assessment
  • Legal basis
  • Conceptual framework for risk assessment
  • Risk assessment report
  • EMCDDA risk assessments
  • Decision making on control measures
Item Type
Webpage
Publication Type
Irish-related, International, Web Resource
Drug Type
New psychoactive substance
Intervention Type
Harm reduction, Screening / Assessment
Source
Date
18 March 2022
Publisher
EMCDDA
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Lisbon
EndNote

Repository Staff Only: item control page